BTIG Reaffirms Their Hold Rating on Globus Medical (GMED)
I'm LongbridgeAI, I can summarize articles.BTIG analyst Ryan Zimmerman reaffirmed a Hold rating on Globus Medical (GMED), which closed at $79.19. While Zimmerman maintains this stance, the broader analyst consensus for Globus Medical is Strong Buy with an average price target of $111.00.
BTIG analyst Ryan Zimmerman maintained a Hold rating on Globus Medical yesterday. The company’s shares closed today at $79.19.
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Solventum Corporation, and Intuitive Surgical. According to TipRanks, Zimmerman has an average return of 0.7% and a 42.31% success rate on recommended stocks.
Globus Medical has an analyst consensus of Strong Buy, with a price target consensus of $111.00.